- $31.20bn
- $31.93bn
- $9.04bn
- 90
- 37
- 75
- 76
Annual balance sheet for Xylem, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,349 | 944 | 1,019 | 1,121 | 1,479 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 953 | 1,096 | 1,617 | 1,668 | 1,759 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 3,160 | 3,012 | 3,884 | 4,098 | 4,641 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 948 | 940 | 1,602 | 1,558 | 1,159 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 8,276 | 7,952 | 16,112 | 16,493 | 17,634 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,391 | 1,590 | 2,205 | 2,336 | 2,856 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 5,058 | 4,458 | 5,946 | 5,851 | 6,154 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 3,218 | 3,494 | 10,166 | 10,642 | 11,480 |
| Total Liabilities & Shareholders' Equity | 8,276 | 7,952 | 16,112 | 16,493 | 17,634 |
| Total Common Shares Outstanding |